Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

Overview of attention for article published in Journal of General Internal Medicine, March 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 4 news outlets
policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 86 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 25,171 followers.

Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial. https://t.co/Tm7Rf5RGDX

09 Oct 2020

Reply Repost Favourite

Open Access UCL Research: Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial https://t.co/7N3UU3mYXL

04 May 2020

Reply Repost Favourite

RT @JournalGIM: Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial…

08 Mar 2019

Reply Repost Favourite

Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial https://t.co/lj6yypxgaQ

08 Mar 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.